Cellebrite DI Ltd
Research Cellebrite DI Ltd (CLBT) on Bullrun: valuation model: 6.7% undervalued, market cap USD 2.82B, P/E 39.6. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCLBT
- ExchangeNASDAQ
- CountryIsrael
- SectorTechnology
- IndustrySoftware-Infrastructure
- CurrencyUSD
- Valuation signal6.7% undervalued
- Market capUSD 2.82B
- P/E39.6
- Financial periodQ1 2026
- RevenueUSD 128.30M
- Net incomeUSD 10.94M
- Free cash flowUSD 9.79M
- Gross margin82.5%
Valuation Snapshot
Bullrun's latest valuation model marks Cellebrite DI Ltd as 6.7% undervalued; latest market cap is USD 2.82B; P/E is 39.6.
Peer valuation comparison
Latest P/E is 39.63x versus a Technology sector median of 28.57x (38.7% above).
Latest P/E is 39.63x versus a Israel median of 24.26x (63.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 475.68M | USD 78.33M | USD 160.32M | 84.2% | 0.31 | USD 124.46M | USD 22.67M | USD 484.32M |
| FY2024 | USD 401.20M | -USD 283.01M | USD 123.61M | 84.4% | -1.35 | USD 191.66M | USD 10.97M | USD 336.02M |
| FY2023 | USD 325.11M | -USD 81.10M | USD 96.83M | 83.6% | -0.43 | USD 189.52M | USD 14.13M | USD 34.21M |
| FY2022 | USD 270.65M | USD 120.81M | USD 13.68M | 81.3% | 0.59 | USD 87.65M | n/a | USD 73.87M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.82B | 39.6 | n/a | n/a |
| 2025 | 2025-12-31 | USD 4.48B | 58.2 | n/a | n/a |
| 2024 | 2024-12-31 | USD 5.17B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 1.71B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 826.87M | 5.2 | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.51B | 160.4 | n/a | n/a |
About Cellebrite DI Ltd
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Related stock research
Other Technology stocks
Frequently asked questions
Is Cellebrite DI Ltd overvalued or undervalued?
Bullrun's valuation model currently marks Cellebrite DI Ltd as 6.7% undervalued.
What is Cellebrite DI Ltd's market cap?
Cellebrite DI Ltd's market capitalization is USD 2.82B.
What is Cellebrite DI Ltd's P/E ratio?
Cellebrite DI Ltd's price-to-earnings (P/E) ratio is 39.6.
What does Cellebrite DI Ltd do?
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.